
|Videos|March 4, 2021
Find out more about Allergan’s presbyopia drop NDA filing
Potential presbyopia treatment coming
Advertisement
Learn more about the recent new drug application (NDA) Allergan submitted for its investigational eyedrop to treat presbyopia. Optometry Times® Editor in Chief Gretchyn Bailey, NCLC, FAAO, chats with Michael Robinson, MD, vice president, global therapeutic area head of ophthalmology at Allergan, to get details on when ODs could discuss a potential presbyopia treatment with their patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Takeaways from this week in optometry: July 27- July 31
2
PROSE treatment improves Mackie stage in neurotrophic keratitis in study
3
Obesity: New definitions and practical implications to know
4
Back to school season provides practice growth opportunities
5























